Heart failure registry: a valuable tool for improving the management of patients with heart failure

被引:142
作者
Jonsson, Asa [1 ]
Edner, Magnus [2 ]
Alehagen, Urban [3 ,4 ]
Dahlstrom, Ulf [3 ,4 ]
机构
[1] Ryhov Cty Hosp, Dept Cardiol, Jonkoping, Sweden
[2] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Stockholm, Sweden
[3] Linkoping Univ Hosp, Dept Cardiol, S-58185 Linkoping, Sweden
[4] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden
关键词
Heart failure; Registry; Diagnostics; Medical treatment; VENTRICULAR SYSTOLIC DYSFUNCTION; QUALITY-OF-CARE; CLINICAL CHARACTERISTICS; HOSPITALIZED-PATIENTS; EJECTION FRACTION; SURVEY PROGRAM; MORTALITY; MORBIDITY; CANDESARTAN; INHIBITOR;
D O I
10.1093/eurjhf/hfp175
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Guidelines on how to diagnose and treat patients with heart failure (HF) are published regularly. However, many patients do not fulfil the diagnostic criteria and are not treated with recommended drugs. The Swedish Heart Failure Registry (S-HFR) is an instrument which may help to optimize the handling of HF patients. The S-HFR is an Internet-based registry in which participating centres (units) can record details of their HF patients directly online and transfer data from standardized forms or from computerized patient documentation. Up to December 2007, 16 117 patients from 78 units had been included in the S-HFR. Of these, 10 229 patients had been followed for at least 1 year, and 2133 deaths were recorded. Online reports from the registry showed that electrocardiograms were available for 97% of the patients. Sinus rhythm was found in 51% of patients and atrial fibrillation in 38%. Echocardiography was performed in 83% of the patients. Overall, 77% of patients were treated with angiotensin converting enzyme inhibitors or angiotensin II receptor blockers, 80% were on beta-blockers, 34% on aldosterone antagonists, and 83% on diuretics. The S-HFR is a valuable tool for improving the management of patients with HF, since it enables participating centres to focus on their own potential for improving diagnoses and medical treatment, through the online reports provided.
引用
收藏
页码:25 / 31
页数:7
相关论文
共 35 条
[1]
Cost of heart failure in Swedish primary healthcare [J].
Agvall, B ;
Borgquist, L ;
Foldevi, M ;
Dahlström, U .
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2005, 23 (04) :227-232
[2]
Cystatin C and NT-proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10-year study in primary care [J].
Alehagen, Urban ;
Dahlstrom, Ulf ;
Lindahl, Tomas L. .
EUROPEAN JOURNAL OF HEART FAILURE, 2009, 11 (04) :354-360
[3]
Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: A report from the Italian Network on Congestive Heart Failure [J].
Baldasseroni, S ;
Opasich, C ;
Gorini, M ;
Lucci, D ;
Marchionni, N ;
Marini, M ;
Campana, C ;
Perini, G ;
Deorsola, A ;
Masotti, G ;
Tavazzi, L ;
Maggioni, AP .
AMERICAN HEART JOURNAL, 2002, 143 (03) :398-405
[4]
Outcome of heart failure with preserved ejection fraction in a population-based study [J].
Bhatia, R. Sacha ;
Tu, Jack V. ;
Lee, Douglas S. ;
Austin, Peter C. ;
Fang, Jiming ;
Haouzi, Annick ;
Gong, Yanyan ;
Liu, Peter P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (03) :260-269
[5]
Systolic and diastolic heart failure in the community [J].
Bursi, Francesca ;
Weston, Susan A. ;
Redfield, Margaret M. ;
Jacobsen, Steven J. ;
Pakhomov, Serguei ;
Nkomo, Vuyisile T. ;
Meverden, Ryan A. ;
Roger, Veronique L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (18) :2209-2216
[6]
A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET) [J].
Cleland, JGF ;
Goode, K ;
Erhardt, L ;
Remme, WJ ;
Charlesworth, A ;
Poole-Wilson, PA ;
Di Lenarda, A ;
Hanrath, P ;
Komajda, M ;
Metra, M ;
Swedberg, K ;
Trop-Pedersen, C .
CARDIOVASCULAR DRUGS AND THERAPY, 2004, 18 (02) :139-152
[7]
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey [J].
Cleland, JGF ;
Cohen-Solal, A ;
Aguilar, JC ;
Dietz, R ;
Eastaugh, J ;
Follath, F ;
Freemantle, N ;
Gavazzi, A ;
van Gilst, WH ;
Hobbs, FDR ;
Korewicki, J ;
Madeira, HC ;
Preda, I ;
Swedberg, K ;
Widimsky, J .
LANCET, 2002, 360 (9346) :1631-1639
[8]
The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe - Part 1: patient characteristics and diagnosis [J].
Cleland, JGF ;
Swedberg, K ;
Follath, F ;
Komajda, M ;
Cohen-Solal, A ;
Aguilar, JC ;
Dietz, R ;
Gavazzi, A ;
Hobbs, R ;
Korewicki, J ;
Madeira, HC ;
Moiseyev, VS ;
Preda, I ;
van Gilst, WH ;
Widimsky, J ;
Freemantle, N ;
Eastaugh, J ;
Mason, J .
EUROPEAN HEART JOURNAL, 2003, 24 (05) :442-463
[9]
The perindopril in elderly people with chronic heart failure (PEP-CHF) study [J].
Cleland, John G. F. ;
Tendera, Michal ;
Adamus, Jerzy ;
Freemantle, Nick ;
Polonski, Lech ;
Taylor, Jacqueline .
EUROPEAN HEART JOURNAL, 2006, 27 (19) :2338-2345
[10]
Incidence and aetiology of heart failure - A population-based study [J].
Cowie, MR ;
Wood, DA ;
Coats, AJS ;
Thompson, SG ;
Poole-Wilson, PA ;
Suresh, V ;
Sutton, GC .
EUROPEAN HEART JOURNAL, 1999, 20 (06) :421-428